Related references
Note: Only part of the references are listed.Increased miR-222 in H. pylori-associated gastric cancer correlated with tumor progression by promoting cancer cell proliferation and targeting RECK
Na Li et al.
FEBS LETTERS (2012)
Wnt/beta-Catenin Signaling in Glioma
Kailiang Zhang et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2012)
Uncovering MicroRNA and Transcription Factor Mediated Regulatory Networks in Glioblastoma
Jingchun Sun et al.
PLOS COMPUTATIONAL BIOLOGY (2012)
EGFR signaling pathway and related-miRNAs in age-related diseases: the example of miR-221 and miR-222
Ana L. Teixeira et al.
Frontiers in Genetics (2012)
Downregulation of the Wnt antagonist Dkk2 links the loss of Sept4 and myofibroblastic transformation of hepatic stellate cells
Atsuko Yanagid et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
NF-kB and c-Jun induce the expression of the oncogenic miR-221 and miR-222 in prostate carcinoma and glioblastoma cells
Silvia Galardi et al.
NUCLEIC ACIDS RESEARCH (2011)
MiR-222 Overexpression Confers Cell Migratory Advantages in Hepatocellular Carcinoma through Enhancing AKT Signaling
Queenie W-L. Wong et al.
CLINICAL CANCER RESEARCH (2010)
MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma
Chun-Zhi Zhang et al.
MOLECULAR CANCER (2010)
Targeting microRNAs in cancer: rationale, strategies and challenges
Ramiro Garzon et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
MicroRNAs in Cancer
Yong Sun Lee et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2009)
MicroRNAs: Target Recognition and Regulatory Functions
David P. Bartel
CELL (2009)
Wnt Antagonist Gene DKK2 Is Epigenetically Silenced and Inhibits Renal Cancer Progression through Apoptotic and Cell Cycle Pathways
Hiroshi Hirata et al.
CLINICAL CANCER RESEARCH (2009)
Activation of Wnt/β-catenin/Tcf signaling pathway in human astrocytomas
Gangadhara Reddy Sareddy et al.
NEUROCHEMISTRY INTERNATIONAL (2009)
Malignant gliomas in adults
Patrick Y. Wen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1*
Silvia Galardi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27(Kip1) protein levels and cell cycle
Rosa Visone et al.
ENDOCRINE-RELATED CANCER (2007)
MicroRNA-cancer connection: The beginning of a new tale
George Adrian Calin et al.
CANCER RESEARCH (2006)
GliaSite brachytherapy for treatment of recurrent malignant gliomas: A retrospective multi-institutional analysis
AJ Gabayan et al.
NEUROSURGERY (2006)
Oncomirs - microRNAs with a role in cancer
A Esquela-Kerscher et al.
NATURE REVIEWS CANCER (2006)
Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets
BP Lewis et al.
CELL (2005)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
Interaction among GSK-3, GBP, axin, and APC in Xenopus axis specification
GH Farr et al.
JOURNAL OF CELL BIOLOGY (2000)
Share Paper
